The Best of Jon & Mike Through the Years

Global Medical Device Podcast · 29 Dec 2022 · 50m · Episode 296

What this episode covers

Jon Speer, founder of Greenlight Guru, and Mike Drues of Vascular Sciences reflect on their 107-episode podcast partnership, discussing key regulatory strategies including the 510(k), De Novo, and Emergency Use Authorization (EUA). They emphasize the importance of understanding all market pathways, interpreting regulations rather than just following them blindly, and conducting realistic usability testing. The conversation highlights the critical mindset of asking whether one would use the device on a family member, underscoring the gravity of medical device development.

Mentioned

Companies
Greenlight Guru, Vascular Sciences
Also
FDA, 510(k), De Novo, Emergency Use Authorization

Other shows on the same ground, closest first.

  • Let's Combinate · 1h 19m

    031 - "The Five Stages Of Regulatory Grief" with Michelle Lott

    Michelle Lott, founder of Lean RAQA, discusses her journey from large manufacturer Baxter Healthcare to consulting for small-to-mid-size medical device companies, highlighting the gap in practical regulatory strategy. She details the 'five stages of regulatory grief' clients experience when facing FDA interactions, contrasting the US 510(k) process with the rigorous, ongoing costs of EU MDR compliance. Lott also explains the nuances of regulations versus guidance documents, the QMSR harmonization, and her unique perspective as an elected industry representative on the FDA Device GMP Advisory Committee.

  • Let's Combinate · 21m

    216 - How UAE and Singapore Are Redefining Regulatory Innovation with Stephen O'Rourke

    Stephen O'Rourke, founder of the consultancy Clarifi, discusses regulatory strategy for MedTech, biotech, and novel food startups navigating EU and US pathways. He highlights the hidden costs of regulatory failure, emphasizing the need for early engagement with agencies and the importance of UDI compliance across all departments. O'Rourke also explores emerging regulatory models in the UAE and Singapore, explaining how regulatory sandboxes and national initiatives are accelerating innovation, and shares insights from his run for the European Parliament on how policy is made.

  • Let's Combinate · 1h 29m

    015 - "Would You Use it on a Family Member?" with Monir El Azzouzi

    Monir El Azzouzi of Easy Medical Device explains the transition from the EU Medical Device Directive (MDD) to the Medical Device Regulation (MDR), highlighting the shift from self-certification to notified body oversight and the impact on private labeling. He details the structural differences between US FDA pathways (510k, PMA) and EU classification rules, noting that MDR requires full technical files for brand owners rather than just distributors. El Azzouzi also discusses the role of notified bodies, the conflict of interest preventing them from offering pre-submission guidance, and the importance of the 'would you use it on your family?' mantra in quality assurance.

  • Being an Engineer · 45m

    S5E7 Matt Zachek | Medical Device Engineering Leaders 7

    Matt Zachek, Senior Director of R&D at Werfen, discusses his career path in medical device engineering, emphasizing the importance of technical foundations, grit, and managing ambiguity. He explains how balancing sustaining products with new R&D efforts requires a strategic portfolio approach, often following a 70-10-10-10 rule. Zachek highlights key industry trends, including the integration of AI tools like Google Gemini for research acceleration and the convergence of consumer electronics with regulated medical devices. He also stresses the value of early manufacturing involvement and in-situ empathy to navigate the complex regulatory landscape of hemostasis and acute care diagnostics.

  • Being an Engineer · 51m

    S6E19 Stuart Grant | MedTech Innovation

    Dr. Stuart Grant, founder of Archetype MedTech, discusses his 25-year career at Johnson & Johnson and DePuy Synthes before launching his consultancy to help startups navigate medical device development. He details the challenges of securing funding, managing regulatory differences between the EU's MDR and the US FDA, and the strategic importance of narrow clinical indications. Grant also explores future trends in surgical robotics and AI, emphasizing the need for modular platforms and the value of accumulated engineering knowledge.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.